1. Home
  2. ADAP vs DTI Comparison

ADAP vs DTI Comparison

Compare ADAP & DTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • DTI
  • Stock Information
  • Founded
  • ADAP 2008
  • DTI 1984
  • Country
  • ADAP United Kingdom
  • DTI United States
  • Employees
  • ADAP N/A
  • DTI N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • DTI Metal Fabrications
  • Sector
  • ADAP Health Care
  • DTI Industrials
  • Exchange
  • ADAP Nasdaq
  • DTI Nasdaq
  • Market Cap
  • ADAP 75.5M
  • DTI 68.0M
  • IPO Year
  • ADAP 2015
  • DTI N/A
  • Fundamental
  • Price
  • ADAP $0.28
  • DTI $2.64
  • Analyst Decision
  • ADAP Buy
  • DTI Strong Buy
  • Analyst Count
  • ADAP 6
  • DTI 1
  • Target Price
  • ADAP $1.52
  • DTI $5.50
  • AVG Volume (30 Days)
  • ADAP 1.6M
  • DTI 56.0K
  • Earning Date
  • ADAP 05-13-2025
  • DTI 05-13-2025
  • Dividend Yield
  • ADAP N/A
  • DTI N/A
  • EPS Growth
  • ADAP N/A
  • DTI N/A
  • EPS
  • ADAP N/A
  • DTI N/A
  • Revenue
  • ADAP $179,639,000.00
  • DTI $160,352,000.00
  • Revenue This Year
  • ADAP N/A
  • DTI $4.26
  • Revenue Next Year
  • ADAP $52.49
  • DTI $6.26
  • P/E Ratio
  • ADAP N/A
  • DTI N/A
  • Revenue Growth
  • ADAP 878.53
  • DTI 8.19
  • 52 Week Low
  • ADAP $0.20
  • DTI $1.43
  • 52 Week High
  • ADAP $1.48
  • DTI $6.36
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 49.68
  • DTI 57.22
  • Support Level
  • ADAP $0.26
  • DTI $2.34
  • Resistance Level
  • ADAP $0.30
  • DTI $2.79
  • Average True Range (ATR)
  • ADAP 0.03
  • DTI 0.22
  • MACD
  • ADAP 0.00
  • DTI 0.01
  • Stochastic Oscillator
  • ADAP 54.53
  • DTI 68.97

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

Share on Social Networks: